KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Receivables (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Change in Receivables for 6 consecutive years, with $11.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables rose 137.55% year-over-year to $11.0 million, compared with a TTM value of $20.6 million through Sep 2025, up 184.34%, and an annual FY2024 reading of -$12.6 million, down 95.95% over the prior year.
  • Change in Receivables was $11.0 million for Q3 2025 at Clover Health Investments, up from -$6.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $19.7 million in Q1 2024 and bottomed at -$29.4 million in Q3 2024.
  • Average Change in Receivables over 5 years is $674368.4, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Change in Receivables surged 1006.71% in 2021, then crashed 2379.85% in 2023.
  • Year by year, Change in Receivables stood at $7.0 million in 2021, then skyrocketed by 96.52% to $13.8 million in 2022, then plummeted by 82.61% to $2.4 million in 2023, then skyrocketed by 494.44% to $14.2 million in 2024, then dropped by 22.33% to $11.0 million in 2025.
  • Business Quant data shows Change in Receivables for CLOV at $11.0 million in Q3 2025, -$6.6 million in Q2 2025, and $2.0 million in Q1 2025.